| Synthesis and characterization of new injectable and degradable dextran-based hydrogels J Maia, L Ferreira, R Carvalho, MA Ramos, MH Gil Polymer 46 (23), 9604-9614, 2005 | 276 | 2005 |
| Insight on the periodate oxidation of dextran and its structural vicissitudes J Maia, RA Carvalho, JFJ Coelho, PN Simões, MH Gil Polymer 52 (2), 258–265, 2011 | 168 | 2011 |
| Nanoparticles and surfaces presenting antifungal, antibacterial and antiviral properties D Botequim, J Maia, MMF Lino, LMF Lopes, PN Simões, LM Ilharco, ... Langmuir 28 (20), 7646–7656, 2012 | 159 | 2012 |
| Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles J Maia, T Santos, S Aday, F Agasse, L Cortes, JO Malva, L Bernardino, ... ACS nano 5 (1), 97–106, 2011 | 118 | 2011 |
| Polymeric Nanoparticles to Control the Differentiation of Neural Stem Cells in the Subventricular Zone of the Brain T Santos, R Ferreira, J Maia, F Agasse, S Xapelli, L Cortes, J Bragança, ... ACS Nano 6 (12), 10463–10474, 2012 | 106 | 2012 |
| Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues MG Tânia Lourenço, Joana Paes de Faria, Christian A. Bippes, João Maia, José ... Scientific Reports 6, 21563, 2016 | 105 | 2016 |
| Ocular injectable formulation assessment for oxidized dextran-based hydrogels J Maia, MP Ribeiro, C Ventura, RA Carvalho, IJ Correia, MH Gil Acta Biomaterialia 5 (6), 1948-1955, 2009 | 63 | 2009 |
| Dextran-based materials for biomedical applications J Maia, MB Evangelista, H Gil, L Ferreira Res Signpost 37661, 31-53, 2014 | 61 | 2014 |
| Nanomedicine boosts neurogenesis: new strategies for brain repair T Santos, J Maia, F Agasse, S Xapelli, L Ferreira, L Bernardino Integrative Biology 4, 973-981, 2012 | 41 | 2012 |
| VEGF-functionalized dextran has longer intracellular bioactivity than VEGF in endothelial cells J Maia, H Vazão, DCS Pedroso, CSH Jesus, RMM Brito, M Grãos, MH Gil, ... Biomacromolecules 13 (9), 2906, 2012 | 14 | 2012 |
| Non-leaching nanoparticle formulation for the intracellular delivery of hydrophobic drugs and its use to modulate cell activity and differentiation SFL da, MJJ Oliveira, BL Inácio, ... WO Patent WO2011145963A1, 2011 | 1* | 2011 |
| Composition comprising activated and functionalized prepolymer B Rhonè, C Legros, J Maia, P Gerbouin, M Pereira US Patent US20220380531A1, 2020 | | 2020 |
| 3D Printing Composition for Biomaterials EDOC Estelle COLLIN, Maria PEREIRA, João MAIA, Valentina CIRILLO, Julien ... WO Patent WO2019180208A1, 2018 | | 2018 |
| Antimicrobial complexes F Lino, B David, M João WO Patent WO2013156595 A1, 2013 | | 2013 |
| DUAL PRO-ANGIOGENIC THERAPY BASED ON THE RELEASE OF VEGF165 AND ENDOTHELIAL CELLS DERIVED FROM UMBILICAL CORD STEM CELLS IN A HYBRID NETWORK J Maia, H Vazao, D Pedroso, C Jesus, RMM Brito, M Graos, H Gil, ... INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS 34 (8), 646-647, 2011 | | 2011 |
| Drug Delivery Systems for Tissue Engineering Applications J Maia Universidade de Coimbra, Portugal, 2011 | | 2011 |
Lino Silva FerreiraFaculty of Medicine, University of CoimbraVerified email at uc-biotech.pt
